Others reported ADA(2) activity in populations of ATB, pneumonia, lung cancer, and pleural effusions of any origin with sensitivity and specificity values of ADA(2) ranging from 35% to 94% and 55% to 97%, respectively (19, 20, 68–70). The gene discussed is ADA; the disease is lung cancer.